Pharmathene up 24% on Reports of Insider Buying

by Benzinga Staff
June 21, 2011 11:12 AM | 14 seconds read |
Shares of Pharmathene Inc PIP is up 24% on reports of insider buying. Company's director bought 17,850 shares at $2.69 on June 17. PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Intraday UpdateBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!